SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148071
Filing Date
2017-04-28
Accepted
2017-04-28 16:02:09
Documents
5
Period of Report
2017-06-13
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d382849ddef14a.htm DEF 14A 554637
2 GRAPHIC g382849g18f10.jpg GRAPHIC 29781
3 GRAPHIC g382849g21i07.jpg GRAPHIC 25376
4 GRAPHIC g382849image1.jpg GRAPHIC 209645
5 GRAPHIC g382849new2.jpg GRAPHIC 106999
  Complete submission text file 0001193125-17-148071.txt   1068184
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36668 | Film No.: 17795324
SIC: 2834 Pharmaceutical Preparations